Jeremy Grantham Merck & Co., Inc. Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $31.8 Billion
- Q2 2025
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 6,469,573 shares of MRK stock, worth $567 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
6,469,573
Previous 6,686,596
3.25%
Holding current value
$567 Million
Previous $600 Million
14.67%
% of portfolio
1.61%
Previous 1.95%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,853Shares Held
1.96BCall Options Held
29.2MPut Options Held
29.9M-
Vanguard Group Inc Valley Forge, PA253MShares$22.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.4 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.73 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.17 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $222B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...